Clinical Trials Directory

Trials / Completed

CompletedNCT05345184

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 2

Feasibility, Acceptability, and Preliminary Effectiveness of a Cognitive Behavioral Suicide Prevention-focused Intervention Tailored to Adults Diagnosed With Schizophrenia Spectrum Disorders: Aim 2 RCT

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Investigators will evaluate the feasibility and preliminary effectiveness of modified Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) in comparison to services-as-usual (SAU) in a randomized controlled trial. Investigators will recruit adult clients receiving services at a community mental health (CMH) setting who have a schizophrenia spectrum disorder and recent suicidal thoughts or behaviors within 3 months of screening (n=60). Client participants will be screened, enrolled and randomized to the CBSPp or SAU group. A 4-wave design will include quantitative assessments at baseline (T1), 1-month after baseline (T2), 3-months after baseline (T3), and 5-months after baseline (T4) with in-depth qualitative interviews at T3 for a random sample of adults in the CBSPp group (n=10). Providers (n=12) will be trained to deliver CBSPp and be assessed from T1-T3 to evaluate the implementation process, including in-depth qualitative interviews at T3.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive Behavioral Suicide Prevention for psychosis (CBSPp)Cognitive and behavioral approach to suicide prevention tailored for individuals with psychosis
BEHAVIORALServices as Usual (SAU)Standard psychiatric and behavioral services provided at community mental health (e.g., case management, medication management)

Timeline

Start date
2022-09-01
Primary completion
2025-05-01
Completion
2025-05-01
First posted
2022-04-25
Last updated
2026-03-20
Results posted
2026-03-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05345184. Inclusion in this directory is not an endorsement.